INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Other Current Liabilities
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Other Current Liabilities of $6.12 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2024-11-07
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current liabilities for the quarter ending 2024-09-30 was $6.12K, a 116.11% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current liabilities for the quarter ending 2024-06-30 was -$369.53K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current liabilities for the quarter ending 2024-03-31 was $293.00, a 76.43% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current liabilities for the quarter ending 2023-12-31 was $2.26K, a 22.17% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current liabilities for fiscal 2024 was -$364.15K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current liabilities for fiscal 2023 was -$25.72K, a 189.15% decline from fiscal 2022.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current liabilities for fiscal 2022 was $28.86K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2024-09-30 | $6.12K 10-Q · filed 2024-11-07 | -$363.42K derived: sum of 2 quarters · filed 2024-11-07 | -$363.12K derived: sum of 3 quarters · filed 2024-11-07 | -$360.86K derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | -$369.53K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | -$369.24K derived: sum of 2 quarters · filed 2024-09-18 | -$366.98K derived: sum of 3 quarters · filed 2024-09-18 | -$364.15K 10-K · filed 2024-09-18 |
| 2024-03-31 | $293.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $2.55K derived: sum of 2 quarters · filed 2024-05-08 | $5.38K 10-Q · filed 2024-05-08 | $5.35K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $2.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | $5.09K 10-Q · filed 2024-02-09 | $5.05K derived: sum of 3 quarters · filed 2024-11-07 | $6.30K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-09-30 | $2.83K 10-Q · filed 2024-11-07 | $2.79K derived: sum of 2 quarters · filed 2024-11-07 | $4.04K derived: sum of 3 quarters · filed 2024-11-07 | $6.94K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$37.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $1.21K derived: sum of 2 quarters · filed 2024-09-18 | $4.11K derived: sum of 3 quarters · filed 2024-09-18 | -$25.72K 10-K · filed 2024-09-18 |
| 2023-03-31 | $1.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $4.15K derived: sum of 2 quarters · filed 2024-05-08 | -$25.69K 10-Q · filed 2024-05-08 | -$11.61K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $2.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | -$26.93K 10-Q · filed 2024-02-09 | -$12.85K derived: sum of 3 quarters · filed 2024-02-09 | |
| 2022-09-30 | -$29.84K 10-Q · filed 2023-11-08 | -$15.76K derived: sum of 2 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $14.08K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $28.86K 10-K · filed 2023-08-23 | ||
| 2022-03-31 | $14.78K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |